Based on the Rockwell Medical Inc stock forecast from 2 analysts, the average analyst target price for Rockwell Medical Inc is USD 5.50 over the next 12 months. Rockwell Medical Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Rockwell Medical Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Rockwell Medical Inc’s stock price was USD 1.00. Rockwell Medical Inc’s stock price has changed by -12.28% over the past week, -37.50% over the past month and -39.39% over the last year.
No recent analyst target price found for Rockwell Medical Inc
No recent average analyst rating found for Rockwell Medical Inc
Company Overview Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Read Less
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, del...Read More
Frequently Asked Questions About Rockwell Medical Inc (RMTI) Stock
Based on ratings from 2 analysts Rockwell Medical Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on RMTI's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for RMTI is USD 5.50 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on RMTI's stock to indicate if its overvalued.
The last closing price of RMTI's stock was USD 1.00.
The most recent market capitalization for RMTI is USD 0.05B.
Based on targets from 2 analysts, the average taret price for RMTI is projected at USD 5.50 over the next 12 months.
This means that RMTI's stock price may go up by +450.00% over the next 12 months.
We can't find any ETFs which contains Rockwell Medical Inc's stock.
As per our most recent records Rockwell Medical Inc has 0 Employees.
Rockwell Medical Inc's registered address is 30142 South Wixom road, Wixom, MI, United States, 48393.
You can get more information about it from Rockwell Medical Inc's website at https://www.rockwellmed.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Rockwell Medical Inc (RMTI) Stock
Based on ratings from 2 analysts Rockwell Medical Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on RMTI's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for RMTI is USD 5.50 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on RMTI's stock to indicate if its overvalued.
The last closing price of RMTI's stock was USD 1.00.
The most recent market capitalization for RMTI is USD 0.05B.
Based on targets from 2 analysts, the average taret price for RMTI is projected at USD 5.50 over the next 12 months.
This means that RMTI's stock price may go up by +450.00% over the next 12 months.
We can't find any ETFs which contains Rockwell Medical Inc's stock.
As per our most recent records Rockwell Medical Inc has 0 Employees.
Rockwell Medical Inc's registered address is 30142 South Wixom road, Wixom, MI, United States, 48393.
You can get more information about it from Rockwell Medical Inc's website at https://www.rockwellmed.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RMTI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
